Author

M. D. Bobardt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

P. A. Gallay· 2 shared A. Castellarnau· 1 shared A. K. Chatterjee· 1 shared C. A. Luscombe· 1 shared D. Jochmans· 1 shared G. P. Heery· 1 shared J. K. Fairley· 1 shared J. Neyts· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

P. A. Gallay

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivMar 25, 2021

A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents

T. N. D. Do, K. Donckers, L. Vangeel…·D. Jochmans

This study develops a SARS-CoV-2 replication model using primary human airway epithelial cells to test antiviral agents, finding that remdesivir and interferons inhibit replication while AT-511 does not.

DOI 10.1016/j.antiviral.2021.105122

humanexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivAug 20, 2020

Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro

J. R. A. Paull, G. P. Heery, M. D. Bobardt…·P. A. Gallay

This study evaluates astodrimer sodium's in vitro antiviral and virucidal activity against SARS-CoV-2, showing potent inhibition of replication and infectivity with high selectivity.

DOI 10.1016/j.antiviral.2021.105089

humanexperimental assay

𝕏 PostBluesky